Hisham Dokainish|Koon Teo|Jun Zhu|Ambuj Roy|Khalid F. AlHabib|Ahmed ElSayed|Lia Palileo-Villaneuva|Patricio López?Jaramillo|Kamilu M. Karaye|Khalid Yusoff|Andrés Orlandini|Karen Sliwa|Charles Mondo|Fernando Lanas|Dorairaj Prabhakaran|Amr Badr|Mohamed ElMaghawry|Albertino Damasceno|Kemi Tibazarwa|Émilie Belley-Côté|Kumar Balasubramanian|Magdi H. Yacoub|Mark D. Huffman|Karen Harkness|Alex Grinvalds|Robert S. McKelvie|Salim Yusuf
Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study
Population Health Research Institute|McMaster University|Population Health Research Institute|McMaster University|Chinese Academy of Medical Sciences & Peking Union Medical College|All India Institute of Medical Sciences|King Saud University|University of the Philippines Manila|University of Santander|Aminu Kano Teaching Hospital|Bayero University Kano|UCSI University|Instituto Cardiovascular de Rosario|University of Cape Town|South African Medical Research Council|Mulago Hospital|Universidad de La Frontera|Centre for Chronic Disease Control|Hamad Medical Corporation|Aswan University|Eduardo Mondlane University|Muhimbili National Hospital|Population Health Research Institute|McMaster University|Population Health Research Institute|McMaster University|Hamad Medical Corporation|Aswan University|Northwestern University|Population Health Research Institute|McMaster University|Population Health Research Institute|McMaster University|Population Health Research Institute|McMaster University|Population Health Research Institute|McMaster University
data heart failure hf patients africa asia middle east south americainterchf prospective study enrolled hf patients 108 centers 16 countries 2012 2014 consecutive ambulatory hospitalized adult patients hf enrolled baseline data recorded sociodemographics clinical characteristics hf etiology treatments age sexadjusted results reportedwe recruited 5813 hf patients meanse age5902years 39 female 65 outpatients 31 rural areas 26 hf preserved ejection fraction 1294 africa 2661 asia 1000 middleeast 858 south america participants africaclosely followed asianswere younger lower literacy levels less likely health medication insurance betablockers compared participants regions likely nyha class iv participants south america older higher insurance literacy levels along middle eastern participants likely betablockers lowest proportion nyha iv ischemic heart disease common hf etiology regions except africa hypertensive heart disease commoninterchf describes significant regional variability socioeconomic clinical factors etiologies treatments hf patients africa asia middle east south america opportunities exist improvement healthmedication insurance rates proportions patients beta blockers particularly africa asia